Estudio de comparación de Daratumumab y Velcade (bortezomib) Melfalán-Prednisona (VMP) comparado con Velcade Melfalán-Prednisona (VMP) en participantes con mieloma múltiple no tratado previamente A Phase 3, Randomized, controlled, open-label study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Conbination with VMP (D VMP) in subjects with previously untreated multiple myeloma who are ineligibl for high-dose-therapy- ALCYONE